Search & Analyze
Popular Searches
Emcure Pharmaceuticals Ltd.
Healthcare₹1,882.000.50%
24 Jul, 4:01 PM
CMP₹1,882.00
Mkt Cap₹35.36K Cr
P/E38.25
P/B7.14
ROE19.19%
52W High₹1,944.00
52W Low₹1,260.10
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
38.25
P/B Ratio
7.14
EV/EBITDA
19.40
Price/Sales
3.84
Dividend Yield (%)
0.19
EPS (TTM ₹)
48.73
Book Value (₹)
260.97
ROE (%)
19.19
ROCE (%)
22.49
ROA (%)
8.94
EBITDA Margin (%)
18.31
Net Profit Margin (%)
8.82
Debt/Equity
0.16
Current Ratio
1.71
Interest Coverage
6.53
Asset Turnover
1.01
Working Capital/Sales
4.25
Core EBITDA Growth (%)
19.81
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 60564.15 | 58553.87 | 59858.11 | 66582.51 | 78959.97 |
| Net Sales | 60564.15 | 58553.87 | 59858.11 | 66582.51 | 78959.97 |
| Total Income | 60918.06 | 59188.6 | 60317.16 | 67152.41 | 79687.82 |
| Total Expenditure | 48244.43 | 45254.79 | 48046.29 | 54285.28 | 64271.43 |
| Operating Profit | 12673.63 | 13933.81 | 12270.87 | 12867.13 | 15416.39 |
| Depreciation | 3233.1 | 2448.55 | 2601.18 | 3124.07 | 3841.28 |
| Exceptional Items | -885.94 | — | -61.46 | -99.31 | -103.78 |
| Profit Before Tax | 6573.27 | 9725.48 | 7472.15 | 7272.28 | 9713.49 |
| Tax | 2387.33 | 2699.92 | 1853.7 | 1996.53 | 2638.82 |
| Profit After Tax (PAT) | 4185.94 | 7025.56 | 5618.45 | 5275.75 | 7074.67 |
| EPS (₹) | 21.68 | 36.62 | 29.42 | 27.54 | 36.43 |
| Dividend Payout % | 10 | 30 | 20 | 30 | 30 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 1808.52 | 1808.52 | 1808.52 | 1811.52 | 1894.83 |
| Reserves | 20804.48 | 17907.76 | 23054.23 | 27566.34 | 42448.42 |
| Shareholders Funds | 22730.22 | 19875.48 | 25011.26 | 29522.83 | 44461.86 |
| Total Debt | 23101.59 | 20772.65 | 21816.06 | 20724.91 | 7306.99 |
| Total Liabilities | 66591.06 | 59473.89 | 65734.05 | 77093.67 | 81217.33 |
| Total Assets | 66591.06 | 59473.89 | 65734.05 | 77093.67 | 81217.33 |
| Book Value / Share | 125.0359 | 109.0189 | 137.4757 | 162.1724 | 234.0223 |
| Assets | 66591.06 | 59473.89 | 65734.05 | 77093.67 | 81217.33 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 7044.35 | 7682.07 | 7468.53 | 10972.4 | 8517.05 |
| Investing Activities | -2518.48 | -7887.91 | -4676.85 | -7125.12 | -940.01 |
| Financing Activities | -1889.04 | -1518.51 | -1453.97 | -1642.06 | -8139.57 |
| Net Cash Flow | 2636.83 | -1724.35 | 1337.71 | 2205.22 | -562.53 |
EMCURE
₹1,882.00
+0.5%